Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus Basal-Bolus Regimen in Type 1 Diabetes
NCT00272090Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Primary completion
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial of insulin glargine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Incidence of severe nocturnal hypoglycemia. Started Nov 2002; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00272090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272090.